38
Growth Score
pts
Heat Score
-11 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
2399071
GlycoBioSciences is a pharmaceutical company exclusively devoted to the sale, licensing and development of therapeutic products.
Kevin Drizen: President
About the Company
GlycoBioSciences Inc. is a pharmaceutical company exclusively devoted to the sale, licensing and development of therapeutic products based on our Ionic Polymer Matrix (IPMTM) technology. Our IPM Wound Gel Bio product is FDA cleared under 510 (k)s K123193 and K143527. Glyco has had new patents issued/granted covering its IPM Wound Gel Bio
product and related technology, and other products that utilize Glyco's IPM Technology in the US (US patent 9,821,005) and in Australia and Mexico, and Glyco has patent applications pending in several other countries currently as well.
